Synaptrix Labs secures seed funding from Mark Cuban to enhance its wearable brain-computer interface platform aimed at wheelchair users.
PRIVATEOct 24, 2025
Round Type
Seed
New YorkBiotechnologyHealth CareArtificial Intelligence
Investors
Mark Cuban
Description
Synaptrix Labs recently received seed funding to accelerate its commercial efforts. The funding was led by investor Mark Cuban, emphasizing the company's innovative approach to non-invasive BCI technology. The startup aims to assist wheelchair users through clinical trials. Their AI-driven platform is designed for both clinical and consumer applications.
Who to call at Synaptrix Labs, and when
A new round usually means Synaptrix Labs is about to hire and buy. The teams that reach out first get the meeting.
An alert the day Synaptrix Labs raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Synaptrix Labs, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Synaptrix Labs. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Synaptrix Labs
Location
New York, New York, United States
About
Synaptrix Labs is a startup building a wearable brain-computer interface platform, focusing on non-invasive solutions for individuals with neurological impairments. Their product, Neuralis, employs advanced AI technology to decode EEG signals for precise wheelchair navigation. The company aims to innovate in the neurotech space by prioritizing accessibility and affordability. Founded in 2023, they are gearing up for clinical trials and exploring collaborations in the field.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Synaptrix Labs raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
New YorkBiotechnologyHealth CareArtificial Intelligence